Lattice Therapeutics Inc.
Washington, DC Lattice Therapeutics, Inc.
- UEI
- N661LEYJ4AW1
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 7144 13th Pl NW, Washington, DC 20012, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: proof-of-concept of a customizable, next-generation RNA delivery particle -the broader impact/commercial… | National Science Foundation | $274,947 |
Quick answers
What is Lattice Therapeutics Inc.'s UEI?
Lattice Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is N661LEYJ4AW1.
Where is Lattice Therapeutics Inc. located?
Lattice Therapeutics Inc.'s physical address in SAM.gov is 7144 13th Pl NW, Washington, DC 20012, USA.
Is Lattice Therapeutics Inc. registered in SAM.gov?
Yes. Lattice Therapeutics Inc.'s SAM.gov registration is active through April 21, 2027.
What is Lattice Therapeutics Inc.'s most recent federal award?
Lattice Therapeutics Inc.'s most recent federal grant award is Sbir phase i: proof-of-concept of a customizable, next-generation RNA delivery particle -the broader impact/commercial… (2413714), from National Science Foundation, on July 15, 2024.
On GovTribe
See Lattice Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors